The most plausible therapeutic target of the synthesized compounds was identified through an in silico pharmacophore‐guided target identification approach, and a potential molecular mechanism underlying their bacteriostatic activity has been proposed.
Abstract
The sustainable one‐pot multicomponent reaction between substituted aromatic aldehyde, 2‐aminobenzothiazole, and 4‐hydroxycoumarin molecules using β‐Cyclodextrin as an organocatalyst to synthesize benzothiazolo[3,2‐a]chromeno[4,3‐d]pyrimidin derivatives in excellent yield with short reaction time. Chiral HPLC analysis of representative products (4o) confirmed racemic mixtures (ee ≈ 63%). β‐Cyclodextrin is found to be a highly efficient and recyclable exterior‐surface catalyst, enhancing substrate solubility and organization in aqueous media without imparting stereoselectivity. Further, the antibacterial activity of the newly synthesized derivatives (4a–4t) was evaluated against both Gram‐positive (
Staphylococcus aureus
) and Gram‐negative bacteria (
Pseudomonas aeruginosa
and
Escherichia coli
). Among these, compound
4n
demonstrated the highest potency, with a minimum inhibitory concentration (MIC) of 39 µM against
S. aureus
. Activity against Gram‐negative strains was comparatively lower, likely due to the reduced permeability of their outer membrane. These findings indicate that compound
4n
exhibits promising
bacteriostatic activity
selectively against Gram‐positive pathogens. The most plausible therapeutic target of the synthesized compounds was identified through an
in silico pharmacophore‐guided target identification
approach, and a potential molecular mechanism underlying their
bacteriostatic
activity has been proposed.
An environmentally friendly one‐pot synthesis of pyrazolo[4,3‐
a
]acridine derivatives 4(a–o) has been developed using 1‐butyl‐3‐methylimidazolium acetate ([BMIM]OAc) as a green and recyclable catalyst in ethanol under reflux conditions. The reaction between 5‐aminoindazole, dimedone, and various isatin derivativ...
Anup D. Vadodariya, Savan S. Bhalodiya, Chirag D. Patel et al.· ChemistrySelect· 0 citations
Computational studies supported the structural and pharmacokinetic characteristics of the synthesized compounds, with selected derivatives exhibiting favorable interactions with the c‐KIT kinase active site and generally acceptable drug‐like properties.
Dinesh Pagar, Ranjay Shaw, Hemant Suryavanshi et al.· Chemical Biology and Drug De...· 0 citations
Pyrano[3,2‐c]chromenes are of significant interest in both biology and synthetic methodology. In a one‐pot three‐component reaction of 4‐hydroxycoumarin, malononitrile (or 1,3‐dicarbonyl compound), and aldehyde, basic conditions were found to promote the synthesis for the first time, with ammonia identified as the...
Qi-Sheng Li, Weicheng Zhang, Lu Yan et al.· ChemistrySelect· 0 citations
A new series of compounds was evaluated as prospective in vitro antimalarial agents against the chloroquine‐sensitive 3D7 and chloroquine‐resistant K1 strains of Plasmodium falciparum, and the compound bearing a 4‐chloroaryl moiety was the most active against P. falciparum.
Lina Rezainia, M. Sayahi, Eisa Kaveh Vernousfaderani et al.· Chemistry and Biodiversity· 0 citations
Combining two pharmacophores into one molecule with multiple applications presents interest in the field of medicinal chemistry. Benzo[b]thiophenes are among privileged scaffolds due to their wide biological activities, whereas oxadiazoles are versatile linkers with pharmacological potential. Thus, this article focused...
Nagaraju Madala, Vishal Sharma, S. Vinnakota· Chemistry and Biodiversity· 0 citations
AIM
To develop a sustainable synthetic protocol for novel imidazo[1,2-a]pyrimidine derivatives using an ionic liquid catalyst and evaluate their antimicrobial and anticancer potential.
MATERIALS AND METHODS
Twenty imidazo[1,2-a]pyrimidine derivatives (KTI-1 to KTI-20) were synthesized using a recyclable diisopropylet...
Bhaktiben R. Bhatt, Kamalkishor Pandey, Sagar Patel et al.· Future Medicinal Chemistry· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.